Ładowanie…
84 spółki, które pokrywamy, z czego 78 ocenionych
Każda spółka tutaj przepuszczona przez te same pięć testów wzrostu i generowania gotówki. To opisuje branżę tak, jak raportuje dziś — a nie którą z tych spółek kupić.
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | A | 45,7B USD | 39,19 USD | 65,32 | 17,3B USD | 4,1% |
| HLN | Haleon plc | B+ | 41,4B USD | 9,26 USD | 18,87 | 14,6B USD | 15,1% |
| TAK | Takeda Pharmaceutical Company Limited | B | 30,3B USD | 18,86 USD | 44,01 | 28,7B USD | -3,4% |
| ZTS | Zoetis Inc. | A+ | 29,4B USD | 71,05 USD | 11,71 | 9,5B USD | 27,5% |
| VTRS | VIATRIS INC. | C | 20,5B USD | 17,83 USD | — | 14,7B USD | -23,9% |
| UTHR | United Therapeutics Corporation | B+ | 20,4B USD | 475,45 USD | 17,02 | 3,2B USD | 41,6% |
| NBIX | NEUROCRINE BIOSCIENCES INC | A+ | 14,1B USD | 138,40 USD | 20,29 | 3,4B USD | 20,9% |
| ELAN | Elanco Animal Health Incorporated | A | 11,1B USD | 22,31 USD | — | 5B USD | -4,0% |
| RDY | DR. REDDY’S LABORATORIES LIMITED | B+ | 10,2B USD | 12,25 USD | 17,35 | 3,5B USD | 12,8% |
| ALKS | Alkermes plc. | B | 6,9B USD | 40,85 USD | 107,50 | 1,7B USD | 4,0% |
| HIMS | HIMS & HERS HEALTH, INC. | A- | 6,8B USD | 29,42 USD | — | 2,6B USD | -5,5% |
| LNTH | Lantheus Holdings, Inc. | A+ | 6,5B USD | 99,74 USD | 24,15 | 1,6B USD | 17,7% |
| AMRX | AMNEAL PHARMACEUTICALS, INC. | C | 6,3B USD | 19,77 USD | 40,35 | 3,1B USD | 5,0% |
| KNSA | Kiniksa Pharmaceuticals International, plc | A | 6,2B USD | 75,08 USD | 82,51 | 754M USD | 9,7% |
| LQDA | LIQUIDIA CORPORATION | A+ | 6,1B USD | 68,43 USD | 49,23 | 450,9M USD | 30,7% |
| INDV | Indivior Pharmaceuticals, Inc. | D | 4,2B USD | 35,82 USD | 12,84 | 1,3B USD | 26,7% |
| AMLX | Amylyx Pharmaceuticals, Inc. | D | 3,3B USD | 29,49 USD | — | 0,00 USD | — |
| RGC | Regencell Bioscience Holdings Limited | bez oceny | 3,1B USD | 6,17 USD | — | — | — |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | C- | 2,5B USD | 42,66 USD | — | 830,4M USD | -13,2% |
| HCM | HutchMED (China) LIMITED | D | 2,4B USD | 13,94 USD | 26,81 | 549,1M USD | 3,3% |
| TRLV | TRULIEVE CANNABIS CORP. | D | 2,4B USD | 12,21 USD | — | 1,1B USD | -41,8% |
| PBH | PRESTIGE CONSUMER HEALTHCARE INC. | C+ | 2,2B USD | 46,61 USD | 13,06 | 1,1B USD | 15,6% |
| BCRX | BIOCRYST PHARMACEUTICALS, INC. | A | 2,2B USD | 8,59 USD | — | 940,6M USD | -40,9% |
| PRGO | Perrigo Company plc | F- | 2,1B USD | 15,42 USD | — | 4,1B USD | -41,9% |
| BHC | Bausch Health Companies Inc. | A | 2,1B USD | 5,69 USD | — | 10,9B USD | -10,1% |
| ALVO | ALVOTECH | B | 1,8B USD | 5,75 USD | 57,50 | 586,3M USD | 4,8% |
| XERS | XERIS BIOPHARMA HOLDINGS, INC. | F- | 1,7B USD | 9,10 USD | — | 335,4M USD | -5,1% |
| ETON | Eton Pharmaceuticals, Inc. | A+ | 1,6B USD | 57,68 USD | — | 105,6M USD | 12,0% |
| ANIP | ANI PHARMACEUTICALS, INC | A+ | 1,6B USD | 74,00 USD | 15,98 | 978,4M USD | 11,1% |
| PAHC | Phibro Animal Health Corporation | B | 1,4B USD | 34,45 USD | 14,12 | 1,5B USD | 6,6% |
| HROW | Harrow, Inc. | B- | 1,2B USD | 33,07 USD | — | 275,6M USD | -13,5% |
| CRON | CRONOS GROUP INC. | A | 1,2B USD | 3,34 USD | 16,70 | 179,1M USD | 39,1% |
| AMPH | Amphastar Pharmaceuticals, Inc. | A+ | 1,1B USD | 26,13 USD | 15,46 | 730M USD | 10,8% |
| PCRX | PACIRA BIOSCIENCES, INC. | A | 1B USD | 25,12 USD | 71,77 | 746,2M USD | 2,0% |
| COLL | Collegium Pharmaceutical, Inc. | A+ | 733,5M USD | 22,53 USD | 18,17 | 808,2M USD | 5,9% |
| IRWD | IRONWOOD PHARMACEUTICALS, INC. | C+ | 682,4M USD | 4,13 USD | 5,36 | 389,3M USD | 33,4% |
| AQST | Aquestive Therapeutics, Inc. | C | 587,4M USD | 4,68 USD | — | 54,1M USD | -144,6% |
| TLRY | Tilray Brands, Inc. | C- | 562,5M USD | 4,13 USD | — | 915,5M USD | -13,3% |
| GLAS | Glass House Brands Inc. | D- | 557,2M USD | 6,80 USD | — | 152,9M USD | -33,7% |
| EOLS | EVOLUS, INC. | B | 526,4M USD | 7,97 USD | — | 316,5M USD | -10,8% |
| KMDA | KAMADA LTD | C | 503M USD | 8,72 USD | 22,95 | 191,8M USD | 11,6% |
| TKNO | ALPHA TEKNOVA, INC. | B- | 500,9M USD | 9,33 USD | — | 43,7M USD | -38,4% |
| CGC | Canopy Growth Corp | D- | 398,3M USD | 0,94 USD | — | 207,3M USD | -79,2% |
| EBS | EMERGENT BIOSOLUTIONS INC. | C | 348,1M USD | 6,79 USD | — | 770,2M USD | -23,0% |
| BIOA | BIOAGE LABS, INC. | D- | 323,6M USD | 7,05 USD | — | 10,4M USD | -912,3% |
| INCR | INTERCURE LTD. | C- | 284,9M USD | 5,21 USD | — | 88,2M USD | -13,2% |
| EVO | Evotec SE | D- | 277,3M USD | 1,56 USD | — | 897M USD | -13,1% |
| ANIK | Anika Therapeutics, Inc. | B- | 272,6M USD | 20,37 USD | — | 120,7M USD | -3,1% |
| AKBA | AKEBIA THERAPEUTICS, INC. | C | 248,3M USD | 0,90 USD | — | 219,1M USD | -13,5% |
| SIGA | Siga Technologies INC | F- | 247,9M USD | 3,45 USD | — | 53,7M USD | -5,2% |
| ACB | AURORA CANNABIS INC | D | 230,6M USD | 4,10 USD | 145,20 | 226,3M USD | -42,4% |
| ORGO | ORGANOGENESIS HOLDINGS INC. | B- | 181,4M USD | 1,41 USD | — | 457,5M USD | -18,4% |
| CRDL | Cardiol Therapeutics Inc. | bez oceny | 171,4M USD | 1,71 USD | — | — | — |
| DERM | Journey Medical Corp | C- | 168,2M USD | 6,14 USD | — | 68,2M USD | -9,0% |
| ADCT | ADC Therapeutics SA | D | 162,1M USD | 1,27 USD | — | 79,6M USD | -121,8% |
| LFCR | LIFECORE BIOMEDICAL, INC. | D | 159M USD | 4,20 USD | — | 128,9M USD | -30,0% |
| CPIX | Cumberland Pharmaceuticals Inc. | F- | 114M USD | 7,61 USD | — | 39,9M USD | -27,4% |
| OGI | ORGANIGRAM HOLDINGS INC. | C- | 104,8M USD | 1,10 USD | — | 183M USD | -9,6% |
| CTOR | Citius Oncology, Inc. | bez oceny | 97,6M USD | 1,05 USD | — | — | — |
| ZYBT | Zhengye Biotechnology Holding Limited | D | 61,8M USD | 1,31 USD | 35,03 | 17,3M USD | -60,0% |
| SCYX | SCYNEXIS, Inc. | F- | 43,7M USD | 4,39 USD | 15,14 | 19,2M USD | -53,3% |
| IMCC | IM Cannabis Corp. | C | 36,4M USD | 2,84 USD | — | 32,3M USD | -39,1% |
| RMTI | ROCKWELL MEDICAL, INC. | B- | 33,7M USD | 8,37 USD | — | 69,4M USD | -7,3% |
| CPHI | CHINA PHARMA HOLDINGS, INC. | C- | 32,3M USD | 0,75 USD | — | 3,9M USD | -114,3% |
| BGM | BGM Group Ltd | F- | 27,2M USD | 0,24 USD | — | 37,9M USD | -52,6% |
| AYTU | AYTU BIOPHARMA, INC | C | 24,8M USD | 2,28 USD | — | 57,6M USD | -24,8% |
| TXMD | TherapeuticsMD, Inc. | F- | 23,7M USD | 2,05 USD | — | 3,3M USD | -6,6% |
| RDHL | REDHILL BIOPHARMA LTD. | F- | 22,5M USD | 0,50 USD | — | 286K USD | -150,0% |
| BFRI | Biofrontera Inc. | B- | 17,5M USD | 1,18 USD | — | 46,2M USD | -13,8% |
| TLPH | TALPHERA, INC. | C- | 16,8M USD | 1,18 USD | — | 1K USD | -1 507 600,0% |
| CABR | CARING BRANDS, INC. | F- | 12,8M USD | 1,24 USD | — | 4,2K USD | -183 255,2% |
| APUS | APIMEDS PHARMACEUTICALS US, INC. | bez oceny | 10,9M USD | 7,25 USD | — | — | — |
| INM | INMED PHARMACEUTICALS INC. | D- | 7,6M USD | 1,38 USD | — | 4,5M USD | -278,7% |
| SNOA | SONOMA PHARMACEUTICALS, INC. | B- | 6,1M USD | 1,27 USD | — | 21,9M USD | -10,3% |
| GELS | Gelteq Limited | D- | 5,2M USD | 0,55 USD | — | 116,3K USD | -4011,9% |
| SBFM | Sunshine Biopharma Inc. | C- | 3,3M USD | 0,84 USD | — | 35,3M USD | -16,5% |
| SHPH | SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | bez oceny | 3M USD | 4,01 USD | — | — | — |
| UPC | Universe Pharmaceuticals INC | D- | 2,7M USD | 4,75 USD | — | 17,9B USD | -20,6% |
| SXTC | China SXT Pharmaceuticals, Inc. | F- | 2,5M USD | 2,57 USD | — | 1,1M USD | -545,2% |
| YCBD | cbdMD, Inc. | D- | 1,9M USD | 0,47 USD | — | 20,9M USD | -13,8% |
| IXHL | Incannex Healthcare Inc. | F- | 1,7M USD | 3,32 USD | — | 0,00 USD | — |
| PRFX | PRF Technologies Ltd. | B- | 811,3K USD | 0,98 USD | — | 17K USD | -29 541,2% |
| AKAN | AKANDA CORP. | F | 210,3K USD | 3,05 USD | 0,24 | 258,1K USD | -17 690,2% |
| OPTH | Optimi Health Corp. | bez oceny | — | 4,82 USD | — | — | — |
Fundamenty z raportów do SEC, kursy z ostatniego przebiegu danych rynkowych. Sortuj po dowolnej kolumnie; spółki bez liczby lądują na końcu w obie strony.
Posortowane według kapitalizacji, od największej; kliknij dowolną kolumnę, żeby posortować inaczej. Spółki bez liczby lądują na końcu w obie strony, bo brak C/Z oznacza stratę, a nie okazję. Nic tutaj nie jest rekomendacją.